Crossmark

Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study

Crossref DOI link: https://doi.org/10.1007/s00592-022-01978-w

Published Online: 2022-11-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zou, Yutong

Zhao, Lijun

Zhang, Junlin

Wang, Yiting

Wu, Yucheng

Ren, Honghong

Wang, Tingli

Zhao, Yuancheng

Xu, Huan

Li, Lin

Tong, Nanwei

Liu, Fang https://orcid.org/0000-0003-1121-3004
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81970626)
License Information

Text and Data Mining valid from 2022-11-01

Version of Record valid from 2022-11-01
More Information

Article History

Received: 8 August 2022

Accepted: 18 September 2022

First Online: 1 November 2022

Declarations

:

: The authors have no conflict of interests to disclose, and the results in this paper have not been published previously in whole or part.

: The study protocol was approved by the Institutional Review Board at the West China Hospital of Sichuan University [number 2013R01], and written informed consent was obtained from all participants.

: All patients have given informed consent.

: Written informed consent for publication was obtained from all participants.

Document is current

Any future updates will be listed below